-
1
-
-
34548402886
-
Human papillomavirus, vaccines and women's health: Questions and cautions
-
Lippman A, Melnychuk R, Shimmin C, et al. Human papillomavirus, vaccines and women's health: questions and cautions. CMAJ 2007;177:484-7.
-
(2007)
CMAJ
, vol.177
, pp. 484-487
-
-
Lippman, A.1
Melnychuk, R.2
Shimmin, C.3
-
2
-
-
56449123227
-
HPV type 6/11/16/18 vaccine: First analysis of cross-protection against persistent infection, cervical intraepithelial neoplasia (CIN), and adenocarcinoma in situ (AIS) caused by oncogenic HPV types in addition to 16/18
-
Presented at the, Sep 17-20; Chicago IL
-
Brown D. HPV type 6/11/16/18 vaccine: first analysis of cross-protection against persistent infection, cervical intraepithelial neoplasia (CIN), and adenocarcinoma in situ (AIS) caused by oncogenic HPV types in addition to 16/18. Presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; 2007 Sep 17-20; Chicago (IL).
-
(2007)
47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
-
-
Brown, D.1
-
3
-
-
37049012913
-
-
Brisson M. The health and economic burden of HPV infection, genital warts, cervical dysplasia and cervical cancer in Canada [presentation]. Presented at the 7th Canadian Immunization Conference; 2006 Dec 3; Winnipeg (MB). Available: www.phac-aspc.gc.ca/cnic-ccni/2006/pres/_pdf-sun-dim-dec03/4- Hall-B-Viral-Diseases-and-Vaccines/Brisson_BOI-HPV_Imm-Conference-2006.pdf (accessed 2007 Oct 26).
-
Brisson M. The health and economic burden of HPV infection, genital warts, cervical dysplasia and cervical cancer in Canada [presentation]. Presented at the 7th Canadian Immunization Conference; 2006 Dec 3; Winnipeg (MB). Available: www.phac-aspc.gc.ca/cnic-ccni/2006/pres/_pdf-sun-dim-dec03/4- Hall-B-Viral-Diseases-and-Vaccines/Brisson_BOI-HPV_Imm-Conference-2006.pdf (accessed 2007 Oct 26).
-
-
-
-
4
-
-
27944485233
-
Recurrent respiratory papillomatosis: Pathogenesis to treatment review
-
Lee JH, Smith RJ. Recurrent respiratory papillomatosis: pathogenesis to treatment review. Curr Opin Otolaryngol Head Neck Surg 2005;13:354-9.
-
(2005)
Curr Opin Otolaryngol Head Neck Surg
, vol.13
, pp. 354-359
-
-
Lee, J.H.1
Smith, R.J.2
-
5
-
-
1642270841
-
Human papillomavirus in oral exfoliated cells and risk of head and neck cancer
-
Smith EM, Ritchie JM, Summersgill KF, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 2004;96:449-55.
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 449-455
-
-
Smith, E.M.1
Ritchie, J.M.2
Summersgill, K.F.3
-
6
-
-
0042464576
-
-
Public Health Agency of Canada, Ottawa; Health Canada;, Available:, accessed Oct 26
-
Public Health Agency of Canada. Cervical cancer screening in Canada: 1998 surveillance report. Ottawa; Health Canada; 2002. Available: www.phac-aspc.gc.ca/publicat/ccsic-dccuac/index.html (accessed 2007 Oct 26).
-
(2002)
Cervical cancer screening in Canada: 1998 surveillance report
-
-
|